FARALLON CAPITAL MANAGEMENT, L.L.C.
SAN FRANCISCO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$19.19B2026 Q3+ $4.02B options (notional, not included)
Positions116
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.60.6%
Top Holdings
SPYPUT
SPDR S&P 500
17.1%
RVMD
Revolution Medicines
11.9%
WBD
Warner Bros. Discovery
6.6%
NTRA
Natera
4.6%
BBIO
BridgeBio Pharma
4.0%
PTGX
Protagonist Therapeutics
3.9%
EXEL
Exelixis
3.7%
ROIV
Roivant Sciences
3.4%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.